NEW VIDEO GAME COMPANY DEEPWELL DTx UNITES GAMES VETS & MEDICAL EXPERTS TO HARNESS THE THERAPEUTIC POWER OF INTERACTIVE ENTERTAINMENT
Retrieved on:
Tuesday, March 15, 2022
HHS, Sissel v. United States Department of Health & Human Services, Devolver Digital, American, World, Patient, Treatment, WHO, Public health, Therapy, Katy Deepwell, FDA, Lists of diseases, COVID-19, Disability, LON, Neonatal Behavioral Assessment Scale, Video game, Video, Single-frequency network, Depression, World Health Organization, Systematic review, Medication, Medicine, Anxiety, Mental health, Founder, Health, Medtech, Etal, Research, CEO, Wilson, Journal of Psychopathology and Behavioral Assessment, American McGee, Human services, Advisory board, Brabantsche Compagnie, The Advisory Board Company, Video game console, Pharmaceutical industry, Hospital, Psychopathology
SEATTLE, March 15, 2022 /PRNewswire/ -- Revealed today after months of development, research, and recruiting, DeepWell Digital Therapeutics (DTx) is a first-of-its-kind video game publisher and developer dedicated to creating best-in-class gameplay that can simultaneously entertain and deliver, enhance, and accelerate treatment for an array of globally pervasive health conditions.
Key Points:
- DeepWell is the creation of Devolver Digital (LON:DEVO) Co-Founder Mike Wilson and Ryan Douglas, the Founder and former CEO of international medical device company Nextern.
- DeepWell isalready hard at work on a slate of DTx-enabled games that will support the company's patented technical processes and systems.
- "But the scientists who study video games, as well as the developers that build them at the highest levels, already know that the opposite is true1.
- DeepWell is a video game developer and publisher dedicated to making games that are simultaneously world-class entertainment, as well as therapeutic for a myriad of health concerns.